Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
depression
Marketing
Johnson & Johnson launches ‘Generation Fine’ depression project
You’ve heard of Gen Z, but now J&J wants you to be aware of “Generation Fine” as it looks to boost understanding around depression treatment.
Ben Adams
May 8, 2026 9:44am
FDA signs off on Johnson & Johnson's Spravato as a monotherapy
Jan 21, 2025 3:23pm
Intra-Cellular moves closer to Caplyta depression expansion
Apr 16, 2024 2:27pm
Bausch starts first TV campaign for seasonal depression drug
Oct 27, 2023 9:20am
AbbVie gives Vraylar ad campaign 'a lift' with new focus
May 9, 2023 9:40am
Intra-Cellular's Caplyta posts sweeping win in depression trial
Mar 29, 2023 11:30am
